Mouse Lung Cancer Models
Mouse Lung Cancer Models - Related Videos
02:36
Establishing a Mouse Model of Pleural Disseminated Lung Cancer
0 Views •
2025
This video demonstrates a method to generate a mouse model of pleural dissemination by injecting lung cancer cell suspension into the thoracic cavity of an immunodeficient mouse.
06:57
Instillation and Fixation Methods Useful in Mouse Lung Cancer Research
0 Views •
Cited by 48 •
2015
The goal of this paper is to describe simple methods that will greatly aid in the setup and analysis of mouse lungs with lung cancer or other pathologies. We present 3 protocols to simply and reliably carry out lung instillations, fixation, and lung volume measurements.
07:46
A Minimally Invasive Method for Generating a Syngeneic Orthotopic Mouse Model of Lung Cancer
0 Views •
2025
A major challenge of developing new therapies for lung cancer includes modeling the tumor microenvironment as regional disease progresses to metastatic disease. Here, we describe a simple method of establishing an orthotopic syngeneic model of lung cancer that allows for in vivo tracking of disease over time.
11:31
Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
0 Views •
Cited by 11 •
2016
We describe a method for the detection of tumor nodule development in the lungs of an adenocarcinoma mouse model using micro-computed tomography and its use for monitoring changes in nodule size over time and in response to treatment. The accuracy of the assessment was confirmed with end-point histological quantification.
09:22
Mouse Pneumonectomy Model of Compensatory Lung Growth
0 Views •
Cited by 14 •
2014
Mouse pneumonectomy is a commonly employed model of compensatory lung growth. This procedure can be used in conjunction with lineage tracing or transgenic mouse models to elucidate underlying mechanisms.
FAQs
Genetically engineered mutations can model tumor development driven by defined genetic changes, whereas carcinogen exposure reflects tumor initiation following an external trigger. Transplantation of tumor cells and implantation into lung tissue provide other experimental routes. Because each approach reproduces different features of tumor biology and the immune microenvironment, model selection should match the biological question being investigated.
Tumors interact continuously with host tissues, including components of the immune microenvironment. Mouse lung cancer models allow researchers to examine these interactions alongside tumor growth and progression rather than studying cancer cells in isolation. This context is especially relevant when investigating immunotherapy, because treatment evaluation can account for how the tumor and surrounding host environment influence one another.
These models support investigation across multiple stages of cancer biology, including tumor initiation, progression, and metastasis. Studying these processes in sequence helps researchers examine how a tumor develops, changes over time, and spreads to other sites. The same experimental framework can therefore connect early tumor formation with later disease behavior and treatment-related questions.
Genetically engineered approaches generate tumors through specified mutations, while carcinogen exposure uses an external cancer-causing stimulus to initiate tumor development. This distinction gives researchers different ways to study how lung tumors arise. The appropriate strategy depends on whether the investigation centers on defined genetic drivers or on tumor initiation associated with carcinogen exposure.
The overview identifies four principal strategies: introducing genetically engineered mutations, exposing mice to carcinogens, transplanting tumor cells, and implanting tumor material into lung tissue. These approaches create experimental systems with different biological characteristics. Researchers can select among them according to whether they need to study tumor initiation, tumor-host interactions, progression, metastasis, or therapeutic response.
Mouse lung cancer models are used during preclinical evaluation, before clinical testing in people. They provide a living framework for examining targeted therapies, chemotherapy, and immunotherapy in relation to tumor biology and host tissues. Results can help investigators refine treatment strategies and assess how a candidate intervention performs within the broader tumor and immune context.
Because these models support analysis of tumor development, progression, metastasis, and treatment response, they can provide a framework for identifying biomarkers associated with those processes. Biomarkers may then help investigators interpret disease behavior or treatment effects within the experimental system. This information can contribute to refining therapeutic strategies before clinical testing.